tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Tempest Therapeutics treatment of FAP granted FDA orphan designation

Tempest Therapeutics (TPST)’ treatment of familial adenomatous polyposis was granted orphan designation by the FDA, according to a post to the agency’s website.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1